Latest news
Jade Therapeutics: Buy Rating Reiterated as Strong Cash Position and Pipeline Progress Support Unchanged $42 Price Target - TipRanksTipRanks · Mon, 10 Aug 2026 18:24:32 GMTDefinium Therapeutics: Buy Rating Reiterated on Strong Clinical and Financial Positioning; $74 Price Target Maintained - TipRanksTipRanks · Sat, 08 Aug 2026 02:49:54 GMTSyndax Buy Rating Reaffirmed as Analyst Sees Transitory Demand Weakness, Strong Menin Positioning and Pipeline Catalysts Supporting Unchanged $57 Target - TipRanksTipRanks · Wed, 05 Aug 2026 13:36:36 GMTSilver Price Outlook: Cooler PCE and Strong Positioning Target $63-$68 - FXEmpireFXEmpire · Fri, 31 Jul 2026 16:31:00 GMT